Navigation Links
Bionovo to Present Positive Results from Phase 2 Trial of Menerba for Vasomotor Symptoms to the International Community
Date:9/3/2009

EMERYVILLE, Calif., Sept. 3 /PRNewswire-FirstCall/ -- Bionovo, Inc. (Nasdaq: BNVI) announced it will be presenting the positive results from the phase 2 clinical trial of their lead drug candidate for postmenopausal symptoms, Menerba, to the international community at the 8th Annual European Society for Gynecology (EGS) in Rome, Italy.

The phase 2 clinical trial was designed to evaluate the safety and efficacy of two doses of Menerba versus placebo. The trial was a randomized, double-blinded, placebo-controlled study that enrolled 217 healthy postmenopausal women reporting moderate to severe hot flashes. Highlights from the trial include:

  • After 12 weeks of treatment, there was a statistically significant decrease in frequency of all hot flashes in the higher dose of Menerba (p=0.04).
  • There was a clear dose response trend in multiple efficacy analyses.
  • Menerba reduced the number of times women were awakened from sleep due to hot flashes (night sweats). The median percent reduction in night sweats in the higher dose of Menerba was 67%, statistically superior to placebo (p=0.05).
  • Compliance and study retention was excellent: 98% of participants completed the trial, with 91% of participants taking at least 75% of the assigned study medication.
  • The only statistically significant adverse event was "transient loose stools" (12% on Menerba vs. 3% on placebo).
  • During the trial, there was no difference in the number of uterine bleeding episodes between the treatment groups and placebo and no cases of endometrial hyperplasia or uterine cancer, further demonstrating Menerba's excellent safety profile.
  • After 12 weeks of treatment, participants taking Menerba experienced lower
    '/>"/>

SOURCE Bionovo, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Bionovo Presents Positive Results from Phase 1B Trial of Bezielle for Metastatic Breast Cancer
2. Bionovo to Present at the BMO Capital Markets Ninth Annual Focus on Healthcare Conference
3. Bionovo Announces Arbitration Decision in Lawsuit Filed by Former Officer - All Claims Denied
4. Bionovo, Inc. to Announce First Quarter Fiscal Year 2009 Financial Results on Thursday, May 7, 2009
5. Bionovo to Present at the Cambria Capital Investor Meeting
6. Bionovo to Present at Wall Street Analyst Forums 20th Annual Institutional Investor Conference
7. Bionovo, Inc. to Announce Fourth Quarter and Year-End Financial Results on Thursday, March 12, 2009
8. Jan Ake Gustafsson, M.D., Ph.D., Joins Bionovos Scientific Advisory Board
9. Bionovo Announces Presentation at the National Cancer Institute
10. Bionovo Announces Cost Control Measures Taken
11. Willa A. Hsueh, M.D., Joins Bionovos Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... Agricultural and Forestry University in Shaanxi province, and the ... agreement that lays the groundwork for establishing the Sino-U.S. ... The signing ceremony was held in the city of ... the U.S. Department of Agriculture and China,s Ministry of ... event for UC Davis and for our World Food ...
(Date:7/23/2014)... FL (PRWEB) July 23, 2014 Rich Dad® ... the success of their charity yard sale to support Habit ... raised and 100% of the proceeds will be donated to ... the event are being donated to the Habitat for Humanity ... Myers, Florida 33903. , One of the highlights of ...
(Date:7/23/2014)... CA (PRWEB) July 23, 2014 Global ... delivering Enhanced External Counterpulsation (EECP), is celebrating ... receives EECP therapy at the health center. , ... heart disease. Since receiving ongoing EECP therapy since 1999, ... When Sara Soulati, CEO of Global Cardio Care, introduced ...
(Date:7/23/2014)... FL (PRWEB) July 23, 2014 Bodybuilding.com, ... largest online retailer of nutritional supplements, has officially opened ... BPI SPORTS , the fastest growing sports nutrition ... categories: , Brand of the Year, Best Tasting Protein ... Year, Protein Powder of the year - Whey-HD™, Pre-workout ...
(Date:7/23/2014)... secrets to better treating the pernicious disorders of obesity ... paper from American University,s Center for Behavioral Neuroscience. In ... with therapies aimed at areas of the brain responsible ... the hippocampus could play a role in reducing certain ... and preventive measures often fall short. This is a ...
Breaking Medicine News(10 mins):Health News:Global food safety research agreement signed by China and UC Davis 2Health News:Global food safety research agreement signed by China and UC Davis 3Health News:Rich Dad Education Charity Yard Sale Raises Over $650 for Habitat for Humanity of Lee and Hendry Counties 2Health News:Global Cardio Care Celebrates EECP Patient’s 100th Birthday 2Health News:Vote Now; BPI SPORTS is Nominated for Eight 2014 Bodybuilding.com Supplement Awards 2Health News:Vote Now; BPI SPORTS is Nominated for Eight 2014 Bodybuilding.com Supplement Awards 3Health News:Targeting the brain to treat obesity 2Health News:Targeting the brain to treat obesity 3
... This month, Pakistan is introducing a new combination vaccine ... influenzae type b (Hib) and four other common childhood ... deadly meningitis and pneumonia, is one of the top ... with treatment, an estimated 23,000 children die of Hib ...
... Calif., Oct. 31 David J. Pecker,Chairman and ... Chris,Lockwood, Mike Carlson, and Allan Donnelly have joined ... Muscle & Fitness Hers magazines, reporting to,Laya Clark ... of AMI,s Enthusiast Group. The Group includes these ...
... blood transfusions,3-year recovery, NEW YORK, Oct. 31 ... Matthew Long, a blood transfusion,recipient, to the New York ... City firefighter, former triathlete and competitive marathoner, was,critically injured ... bus while,biking to work on December 23, 2005. He ...
... Pregnant women whose labor stalls while in the active phase ... infants by waiting out the delivery process for an extra ... the University of California, San Francisco. , By doing ... the more dangerous and expensive surgical approach per year ...
... calorie burn , , FRIDAY, Oct. 31 (HealthDay News) -- ... stimulant produced by the human body has been discovered. ... antibody catalyst, GHR-11E11, increased the metabolic rate in fasting ... went 24 hours without food. , The antibody counteracts ...
... in this group , , FRIDAY, Oct. 31 (HealthDay News) ... death among kidney failure patients, and inflammation and malnutrition ... these people, Johns Hopkins researchers report. , The researchers ... on dialysis. Over 9.5 years, there were 658 deaths, ...
Cached Medicine News:Health News:Pakistan introduces vaccine to prevent top child killer 2Health News:American Media Inc. Names Chris Lockwood, Mike Carlson, and Allan Donnelly to Lead Editorial Teams at Enthusiast Group of Fitness Titles 2Health News:Blood Recipient Matthew Long Returns to New York Marathon 2Health News:Patience during stalled labor can avoid many C-sections, UCSF study shows 2Health News:Scientists Develop New Strategy to Fight Obesity 2Health News:Kidney Patients More Susceptible to Sudden Cardiac Death 2
(Date:7/23/2014)... July 23, 2014 The Board of Directors ... leading provider of clinical trial imaging solutions, announced today ... named president and chief executive officer, effective immediately.  Mr. ... 2013 and has held the positions of interim president ... Dr. Charles E. Phelps , Ph.D., chairman ...
(Date:7/23/2014)... , July 23, 2014 Pharmavite LLC ... company,s chief customer officer effective immediately. Toll recently served ... sales and marketing, category management, private label and sales ... In his new global role, Toll will expand his ... sales planning. "Toll,s appointment to chief customer ...
(Date:7/23/2014)... , July 23, 2014  RT Oncology Services Corporation ... to join its board of directors. Mr. Mundie is ... where he works on strategic projects within the company ... Microsoft,s chief research and strategy officer. ... of RainTree, said, "Craig is a visionary technology executive. ...
Breaking Medicine Technology:Eric T. Converse Named President And Chief Executive Officer Of VirtualScopics, Inc. 2Eric T. Converse Named President And Chief Executive Officer Of VirtualScopics, Inc. 3Eric T. Converse Named President And Chief Executive Officer Of VirtualScopics, Inc. 4Craig Mundie Joins RainTree Oncology Board of Directors 2Craig Mundie Joins RainTree Oncology Board of Directors 3
Fome-Cuf® tubes can breathe with the patient to provide a safe, effective, and low pressure seal throughout the ventilatory cycle....
Portex® pediatric tracheostomy tubes offer a choice in both form and fit. , ,The anatomical shape of the tube shaft along with the caudal angle of the 15 mm connector provide comfort and security...
Indications For Usage: ,Bypass upper airway obstructions, provide long term ventilation, support and/or manage tracheal/bronchial secretions....
KIMBERLY-CLARK BALLARD Neonatal and Pediatric TRACH CARE Manifold features lavage/irrigation port and locking thumb port. Multiple French sizes and packaging configurations. Gamma sterilized....
Medicine Products: